Serum procalcitonin in systemic autoimmune diseases--where are we now?


OBJECTIVES To review the current evidence regarding the value of measuring procalcitonin (PCT) levels in patients with systemic autoimmune diseases, with a focus on the evidence for diagnostic and analytical performance of this biomarker. A brief description of the pathophysiological basis of this biomarker is also included. METHODS Using PubMed from the… (More)
DOI: 10.1016/j.semarthrit.2009.10.004